Related Experiment Video
Updated: Jun 14, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Pediatric Respiratory Infections After the COVID-19 Pandemic: A Single-Center Experience
Walaa A Shahin1,2, Khaled Alamri2, Eshraq Omar2
1Pediatric Pulmonology, Cairo University Pediatric Hospital, Cairo, EGY.
Insights
Following COVID-19 lockdowns, pediatric respiratory infections surged, with respiratory syncytial virus (RSV) causing more severe illness than COVID-19 in children. This study highlights the aggressive resurgence of common viruses, emphasizing RSV
Area of Science:
- Pediatrics
- Infectious Diseases
- Epidemiology
Background:
- Pediatric respiratory infections, particularly bronchiolitis, represent a significant clinical challenge.
- Respiratory Syncytial Virus (RSV) is the leading cause of bronchiolitis, with other viruses also contributing.
- Understanding post-pandemic viral behavior is crucial for managing pediatric respiratory illnesses.
Purpose of the Study:
- To investigate the epidemiology and clinical features of viral bronchiolitis and flu in children post-COVID-19 pandemic.
- To compare the clinical behavior and outcomes of different viral infections, including RSV, influenza, and COVID-19.
- To analyze seasonal patterns and severity of pediatric respiratory infections.
Main Methods:
- A retrospective observational study conducted over seven months (October 2022 - April 2023).
- Included children aged 0-14 diagnosed with bronchiolitis or flu, with viral etiology confirmed by PCR.
- Collected clinical data, lab results, and X-rays, correlating them with specific viral infections.
Main Results:
- 237 children were recruited; RSV was the predominant virus (63.3%), followed by influenza A/B (13% each) and COVID-19 (10%).
- RSV infections were associated with more severe hypoxia and longer hospital stays compared to other viruses.
- COVID-19 cases presented with milder disease, shorter hospital stays (2 days), and shorter illness duration (5 days).
Conclusions:
- Post-pandemic, a resurgence of aggressive upper respiratory tract infections (URTIs) and flu occurred in children, notably driven by RSV.
- This resurgence led to increased severe respiratory symptoms and hospitalization needs.
- Children with COVID-19 experienced milder illness compared to those infected with RSV.
Abstract:
Background Pediatric respiratory infections, mainly bronchiolitis, are a substantial clinical burden. The most common etiology is respiratory syncytial virus (RSV). Other viruses include human rhinovirus, human metapneumovirus, influenza, adenovirus, coronavirus, and parainfluenza viruses. Objective We aimed to study the epidemiology and clinical characteristics of children with confirmed viral bronchiolitis and flu after the COVID-19 pandemic season and compare the behavior of each virus. Methods This retrospective observation study was done over seven months, from October 2022 to April 2023. All children (0-14) were included in the study if they met the clinical diagnosis of bronchiolitis or flu. Viral etiology is confirmed by PCR, using the respiratory panel available in our center which included the detection of four viruses: COVID-19, RSV, influenza A, and B. Clinical data, lab results, and X-rays were collected and correlated with each viral infection for all admitted patients. Results We recruited 237 children with bronchiolitis and flu symptoms from October 2022 to April 2023. The peak of infections (41%) was in November. Seasonal variations for each virus showed distinct patterns across the year. RSV peaked at the beginning of the season, gradually declining after that. In contrast, influenza A and B maintained a relatively consistent presence throughout the season. Meanwhile, COVID-19 reached its peak during March and April. One hundred forty-four (60%) of the patients were under two years of age. RSV was predominant in 150 patients (63.3%). COVID-19 was only detected in 25 patients (10%), whereas influenza A and B were equally isolated in 31 (13%) patients each. Fifty-one children (21%) were initially sick and required pediatric intensive care unit (PICU) admission, with no deaths reported. Notably, COVID-19 had a milder disease course, a shorter length of stay (LOS) in the hospital (two days) and a shorter duration of illness (five days) compared to other viruses. RSV infection was linked to more profound hypoxia and more sick children with more extended hospital stays. Conclusion Our study showed that, following the pandemic and the release of lockdown measures, there was another peak of upper respiratory tract infections (URTI) and flu, which was more aggressive, primarily due to other viruses, especially RSV. This resurgence was associated with more severe respiratory symptoms and an increased need for hospitalization. Notably, children with COVID-19 were in better condition compared to those with RSV.
Related Concept Videos
Pulmonary Cycle: Exhalation
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...

